The Centre for Cancer Immunology is leading a world-first trans-Atlantic clinical trial that will test a new three-part treatment and give children with an aggressive form of cancer new hope in their fight against the disease.
The study, involving doctors and cancer scientists in Southampton, America and Germany, will boost the body’s immune system to kill off neuroblastoma, one of the most common childhood cancers.
Please read more about the trial here